🧠 Session 1: Innovations in Diagnosis and Management of Parkinson’s Disease
🗓️ September 12, 2025 | 🕒 14:00 – 15:20
This session will address current developments in Parkinson’s disease from its early signs, including the gut-brain axis, molecular subtypes, and biomarkers. Current clinical approaches for treatment in both early and advanced stages will also be comprehensively discussed.
Topics:
- The Hidden Onset of Parkinson’s: From Gut to Brain
- Molecular Pathways and Subtypes: Redefining the Disease
- New Horizons in Diagnosis with Biomarkers
- Current Management Strategies in Early and Advanced Stages
🧠 Session 2: Advanced Interventions and Emerging Technologies in Parkinson’s Disease
🗓️ September 12, 2025 | 🕒 15:40 – 16:20
This session will explore innovative interventional approaches in the treatment of Parkinson’s disease and the latest technological developments shaping the future. A wide range of advanced applications will be evaluated, from surgical techniques to personalized treatment strategies.
Topics:
- Deep Brain Stimulation and Neurosurgical Interventions
- New and Translational Approaches in Parkinson’s Therapy
🧠 Session 3: Interactive Discussion with Young Clinicians and Researchers
🗓️ September 12, 2025 | 🕒 16:40 – 17:40
This interactive session offers young clinicians and researchers in the field of Parkinson’s disease the opportunity to directly engage with experienced professionals. Supported by live participant surveys, the forum will explore research priorities, treatment strategies, and future visions.
Format:
- Expert Panel
- Live Polls and Participant Feedback
- Interactive Q&A and Discussion Sessions
🧠 Session 4: Innovations in Diagnosis and New Therapeutic Targets in Alzheimer’s Disease
🗓️ September 13, 2025 | 🕒 09:00 – 10:00
This session will explore developments in the diagnosis of Alzheimer’s disease and innovations in therapeutic targeting. A multidimensional assessment will be presented, ranging from imaging techniques and biomarker use to early intervention strategies and molecular treatment approaches.
Topics:
- From Silence to Findings: Biomarkers and Imaging Innovations
- Early Detection of Alzheimer’s: Clinical and Functional Indicators
- Neuroinflammation and Early Immunity Triggers
- New Molecular Targets and Disease-Modifying Therapies
🧠 Session 5: Advanced Interventions and Future Therapies in Alzheimer’s Disease
🗓️ September 13, 2025 | 🕒 10:20 – 11:00
This session will evaluate treatment approaches used in advanced stages of Alzheimer’s disease and future promising therapeutic strategies. Discussions will focus particularly on anti-amyloid treatments and neuroprotective approaches aimed at slowing disease progression.
Topics:
- Anti-Amyloid Treatments in Alzheimer’s
- Neuroprotection and Beyond: The Post-Amyloid Era
🧠 Session 6: Interactive Discussion with Young Clinicians and Researchers
This session offers early-career clinical experts and researchers working in the field of Alzheimer’s disease the opportunity to interact directly with experienced professionals. Feedback collected through live audience polls will be discussed by a panel in the context of research priorities and future strategies.
Format:
- Young Investigator Panel
- Poll-Based Discussions
- Dialogue on Mentorship and Future Strategies
🧠 Session 7: Advances in Early Diagnosis and Functional Assessment in Multiple Sclerosis
🗓️ September 13, 2025 | 🕒 13:30 – 15:00
This session will cover current approaches to early diagnosis and functional assessment of disease progression in multiple sclerosis (MS). Topics will include imaging and biomarker-based strategies aimed at pre-symptomatic diagnosis, as well as the role of neuroinflammation in disease progression. Methods for understanding silent progression and personalized monitoring models will also be discussed.
Topics:
- Pre-symptomatic Diagnosis and New Imaging Techniques in MS
- The Role of Neuroinflammation in Disease Progression
- Silent Progression and Personalized Monitoring Approaches
🧠 Session 8: Therapeutic Boundaries in Multiple Sclerosis and Demyelinating Diseases
🗓️ September 13, 2025 | 🕒 15:00 – 16:00
This session will focus on targeted therapeutic approaches for MS and related demyelinating diseases that affect the immune system. Discussions will include personalized treatment strategies for progressive MS, the clinical outcomes of steroid therapy and its discontinuation, as well as how advances in neuroimmunology are shaping future therapeutic applications.
Topics:
- Immune Mechanisms in MS and Targeted Treatment Strategies
- Personalized Approaches and Patient-Centered Management Models for Progressive MS
- Clinical Implications of Steroid Therapy and Treatment Discontinuation
- Impact of Neuroimmunological Research on Future Therapeutic Practices
🧠 Session 9: Interactive Discussion with Young Clinicians and Researchers
🗓️ September 13, 2025 | 🕒 16:20 – 17:20
This interactive session offers young researchers in the field of MS the opportunity to engage with experts and deepen the discussion through real-time interaction. Based on data collected through audience surveys, topics such as clinical priorities, research gaps, and interdisciplinary collaborations will be addressed by the panelists. The session will highlight how the next generation of scientists can shape the future of neurobiology.
Format:
- Young Researcher Panel
- Survey-Based Discussion
- Dialogue on Mentorship and Future Strategic Planning
🧠 Session 10: Immune Targets and New Therapies in Demyelinating Diseases
🗓️ September 14, 2025 | 🕒 09:30 – 10:10
This session will explore current therapeutic approaches in immune-mediated demyelinating diseases such as MOG antibody disease and neuromyelitis optica spectrum disorder (NMOSD). It will focus on how clinical experience aligns with evidence-based data and how personalized treatment strategies are being shaped. Additionally, the expanding role of intravenous immunoglobulin (IVIG) therapy in central nervous system diseases will be assessed from various perspectives.
Topics:
- Bridging Clinical Experience and Evidence in MOG and NMO Therapies
- Management of Expectations in Immune-Mediated Neurological Diseases
- Expanding Role of IVIG Therapy in Central Nervous System Disorders
- Personalized Approaches in Rare Immune-Mediated Demyelinating Disorders
🧠 Session 11: Beyond the Brain – Multidisciplinary Approaches in Neurodegeneration
🗓️ September 4, 2025 | 🕒 10:30 – 11:30
This session will take a multidisciplinary view of the systemic effects of neurodegenerative diseases. Experts from various specialties—such as endocrinology, cardiology, oncology, and physical therapy—will evaluate how body systems and disease processes interact with brain health. Special attention will be given to metabolic and cardiovascular risk factors, immune-oncology relationships, neuropathic pain management, and rehabilitation strategies.
Topics:
- Impact of Endocrine Factors on Neurodegenerative Processes
- Links Between Cardiometabolic Health and Brain Aging
- Interaction of the Immune System, Inflammation, and Nervous System in Oncology
- Comprehensive Neuropathic Pain Management and Physical Therapy Strategies
- Neuroprotective Approaches through Interdisciplinary Collaboration
